BSC
NVAX icon

BOLTON SECURITIES CORPORATION’s Novavax NVAX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$649K Buy
60,015
+30,000
+100% +$269K 0.02% 528
2026
Q2 		$283K Sell
30,015
-11,500
-28% -$103K 0.01% 786
2026
Q1 		$338K Buy
41,515
+10,015
+32% +$90.8K 0.02% 648
2025
Q4 		$212K Buy
31,500
+30,000
+2,000% +$226K 0.01% 762
2025
Q3 		$13K Sell
1,500
-65,000
-98% -$506K ﹤0.01% 1486
2025
Q2 		$419K Buy
66,500
+10,000
+18% +$66.2K 0.02% 544
2025
Q1 		$362K Buy
+56,500
New +$467K 0.02% 561

Other funds holding NVAX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Shah Capital Management
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's NVAX Position: Q3 2026 in Review

BOLTON SECURITIES CORPORATION increased its Novavax (NVAX) stake by 100% in Q3 2026, buying an estimated $269K and bringing the position to 60,015 shares worth $649K. The position accounts for 0.02% of the portfolio, ranked #528.

BOLTON SECURITIES CORPORATION first reported a position in NVAX in Q1 2025 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • BOLTON SECURITIES CORPORATION held 60,015 shares of Novavax worth $649K as of Q3 2026.
  • BOLTON SECURITIES CORPORATION bought 30,000 Novavax shares in Q3 2026, an estimated $269K.
  • Novavax made up 0.02% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2026, its #528 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Novavax in Q1 2025 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2026, filed 12 Nov 2026.